Fruquintinib (Fruzaqla®)

This PQI in Action is a follow up to the Fruquintinib (Fruzaqla®) PQI and explores how the medically integrated teams at Florida Cancer Specialists & Research Institute (FCS) and AtlantiCare Cancer Care Institute (AtlantiCare) collaborate and utilize the information found in the PQI as part of their daily practice. This PQI in Action focuses on the use of fruquintinib to optimize the treatment of patients with previously treated metastatic colorectal cancer (CRC).